Analytical study on the efficacy of neoadjuvant chemotherapy using a combination of methotrexate, bleomycin, and cisplatin in the management of advanced squamous cell carcinoma of... by Santosh Manohar Kumar, Srabani Biswas, Shreya Sarkar, Syam Sundar Mandal, Jaydip Biswas

Subjects: Get full text

ACCELERATED HYPERFRACTIONATED DAY DOSE CHART CHEMORADIATION TREATMENT OF PATIENTS WITH CANCER OF OROPHARYNX AND ORAL CAVITY by M. U. Radzhapova, L. A. Gulidov, Yu. S. Mardynskiy, D. Yu. Semin

Subjects: “…objective response, accelerated hyperfractionation, chemoradiotherapy, late radiation damage, mucositis…”
Get full text

Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab by Jaejun Lee, Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jeong Won Jang, Jong Young Choi, Jong Young Choi, Seung Kew Yoon, Seung Kew Yoon, Ji Won Han, Ji Won Han, Pil Soo Sung, Pil Soo Sung

Subjects: Get full text

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherap... by Weiming Liang, Weiming Liang, Zhijing Wang, Zhilong Huang, Yanping Huang, Chunyan Li, Yiwen Liang, Miaoyan Huang, Duo Zhang, Chenchen Li

Subjects: Get full text

Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis by Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, Juwairiya Shuroog, Ahmed Abdelhakeem, Ali Saeed, Anwaar Saeed

Subjects: Get full text

Clinical experience with romiplostim by G. B. Kuchma, L. K. Kozlova, Ye. Ye. Kuznetsova, S. B. Borisyuk

Subjects: Get full text

Efficacy and safety of nivolumab plus ipilimumab in gastrointestinal cancers: a systematic review and meta-analysis by Bowen Dai, Jiaping Jiang, Xiaoyu Yu, Haihua Zhan, Zhengchuan Hu

Subjects: Get full text

Efficacy of neoadjuvant chemotherapy with docetaxel and cisplatin in patients with squamous cell carcinoma of the oral cavity at high risk of progression by S. I. Kutukova, Yu. V. Ivaskova, N. P. Beliak, G. A. Raskin, A. A. Varankina, A. I. Yaremenko, A. Ya. Razumova, A. O. Cheremnykh, M. F. Manna, R. V. Orlova

Subjects: Get full text

Criteria for evaluation of clinical efficacy of anticancer medicines by A. V. Tikhomirova

Subjects: Get full text

Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors by Anqi Lin, Lihaoyun Huang, Aimin Jiang, Lingxuan Zhu, Weiming Mou, Yu Li, Chunyan Zhang, Zaoqu Liu, Jian Zhang, Quan Cheng, Ting Wei, Peng Luo

Subjects: Get full text

Frequency of microsatellite instability in gynecologic cancers and the efficacy of immune checkpoint inhibitors treated: real-world data from a single gynecologic center by Wei Kuang, Wei Kuang, Jing Zeng, Jing Zeng, Lingling Tong, Lingling Tong, Qianqi Liu, Qianqi Liu, Huanxin Sun, Huanxin Sun, Min Feng, Min Feng, Dongni Liang, Dongni Liang, Wei Wang, Wei Wang, Cheng Wang, Cheng Wang

Subjects: Get full text

Investigation into the Use of Surufatinib and Donafenib as Novel Multi-Kinase Inhibitors Therapeutic Agents in Managing Advanced Differentiated Thyroid Cancer: A Systematic Review by Danut Dejeu, Paula Dejeu, Anita Muresan, Paula Bradea, Viorel Dejeu

Subjects: Get full text

Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma by Hongmei Zhou, Min Zhang, Yi Jin, Xianghua Lang

Subjects: Get full text

Neoadjuvant treatment in locally advanced thyroid cancer: a single institution experience by Ling-Feng Xu, Nuo Shi, Jia-Liang Niu, Ning An, Yi-Qing Xi, Qiu-Yi Huang, Liang Jiang, Jian Chen

Subjects: Get full text

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis by Zhe Wang, Danxue Huang, Su Li, Liyuan Ke

Subjects: Get full text

Optimal early endpoint for second-line or subsequent immune checkpoint inhibitors in previously treated advanced solid cancers: a systematic review by Jingqiu Li, Xiaoding Zhou, Lei Wu, Jiabao Ma, Yan Tan, Songke Wu, Jie Zhu, Qifeng Wang, Qiuling Shi

Subjects: Get full text

The delaying effect of toripalimab on disease progression in patients with advanced hepatocellular carcinoma and changes in serum tumor markers by Zhuo Yin, Yaomin Xiao, Jiangxue Gu, Pei Hu, Jiandu Jing, Xia Wang, Yao Liu, Shirong Yan

Subjects: Get full text

Influencing factors of early objective response of unresectable hepatitis B virus⁃related liver cancer with triple therapy by YU Jin*，LI Xiaogang

Subjects: Get full text

Organ‐Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study by Jung Sun Kim, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Jung Yong Hong, Ho Yeong Lim, Han Sang Kim, Chang Gon Kim, Sanghoon Jung, Chansik An, Chan Kim, Hong Jae Chon

Subjects: Get full text

Efficacy and safety of first-line PD-1/PD-L1 inhibitor in combination with CTLA-4 inhibitor in the treatment of patients with advanced non-small cell lung cancer: a systemic review... by Huimin Zhao, Shanshan Huang, Jianyu Wu, Yanlan Lu, Yue Zou, Haijian Zeng, Chunlan Li, Jin Wang, Xiaochen Zhang, Xiaochen Zhang, Siliang Duan, Siliang Duan, Weiming Liang

Subjects: Get full text